Augusta University: National Cancer Institute-Sponsored Trial Explores Better Treatment For Brain Tumors in Children
October 09, 2019
October 09, 2019
AUGUSTA, Georgia, Oct. 9 [TNSmedicalresearch] -- Augusta University issued the following news release:
Children with recurrent brain tumors or newly diagnosed, particularly aggressive tumors called diffuse intrinsic pontine gliomas are being enrolled in the first study to examine the efficacy of a drug that inhibits an enzyme these tumors use to protect themselves from the child's natural immune response.
The study, sponsored by a $3 million grant from the National Canc . . .
Children with recurrent brain tumors or newly diagnosed, particularly aggressive tumors called diffuse intrinsic pontine gliomas are being enrolled in the first study to examine the efficacy of a drug that inhibits an enzyme these tumors use to protect themselves from the child's natural immune response.
The study, sponsored by a $3 million grant from the National Canc . . .